International Journal of Pharmaceutical Sciences and Drug Research

51-55

Authors: Mehul K Bhatt1*, Nehal Shah2

There are a large number of traditional plants, their extracts and phytoconstituents presently used in modern medicine. There is a worldwide majority of the population that still relies on plants as a source of medicine. One of the medicinally useful plant is Hygrophila salicifolia. Hygrophila salicifolia is an erect herb (family: Acanthaceae). It has many medicinal uses like diuretic and anti inflammatory in traditional systems of medicine. Till date no data available for its Phytoconstituents therefore isolation of phytoconstituent was done from methanolic extract of Hygrophila salicifolia. Flavonoid was isolated for the first time from a Hygrophila salicifolia (Acanthaceae). Its structure was established on the basis of its spectroscopic data such as UV, IR, Mass, NMR, Melting point, HPTLC and laterally confirmed as Isoquercitrin.

61-70

Authors: Mensura Sied Filli1#, Ahmed Abdalla Ibrahim2#, Md Aquib1, Abdul Baset Abbas3, Arwa Morshed3, Kofi Oti Boakye-Yiadom1, Samuel Kesse1, Muhammad Asim Farooq1, Mily Bazezy1, Bo Wang1*

Cancer is a leading cause of death throughout the world which suffers from treatment failures mainly due to intensive toxicity and lack of effectiveness of conventional drugs. The application of nanotechnology in cancer treatment promises to overcome the drawbacks of conventional drugs/dosage forms and improve their therapeutic efficacy. Nanomaterials have novel properties that influence their in vivo performance. The biological behaviour of nanotechnology-based medicines in the body, which is different from the in vivo performance of conventional drug delivery systems, may provide benefits in pharmaceutical and/or clinical applications including, enhancements in solubility, stability, therapeutic efficacy, minimized side effects, and treatment of diseases. This paper discusses the unique characteristics and distinguished advantages of nanomaterials as anticancer drug carriers. Physicochemical properties of nanomaterials are critical parameters to their clinical translation. Hence, the impact of the main physicochemical properties on the efficacy of anticancer nanomaterials, which are found to effective for cancer treatment and/or diagnosis, are presented. It is important to have reliable and robust characterization techniques that could enable relate physicochemical properties of nanomaterials with their in vivo behaviour. Brief explanation of the different techniques that can be used for studying the various physicochemical characteristics of nanomaterials is given. An important consideration, to achieve fast and successful development of nanotechnology-based anticancer drug products, is assessment and optimization of physicochemical and biopharmaceutical properties at the early stage. Obviously this requires collaboration among the different discovery and development scientists.